SaNOtize Research and Development Corp. (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced that the company has appointed Steven Basta, an experienced biopharma and medical device commercial leader, as its new Chief Executive Officer (CEO). Co-Founder Gilly Regev, PhD, will transition from her role as CEO to Chief Strategy and Innovation Officer at SaNOtize and will remain a member of its Board of Directors.

https://www.businesswire.com/news/home/20230925232677/en/SaNOtize%E2%80%99s-Board-Appoints-Steven-Basta-as-New-Chief-Executive-Officer